Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Alessandro Levis"'
Autor:
Emanuela Messa, Daniela Gioia, Elisa Masiera, Anna Castiglione, Manuela Ceccarelli, Flavia Salvi, Paolo Danise, Alessandro Sanna, Bernardino Allione, Enrico Balleari, Antonella Poloni, Giovanni Cametti, Dario Ferrero, Rodolfo Tassara, Carlo Finelli, Margherita Bonferroni, Pellegrino Musto, Giuseppe Saglio, Alessandro Levis, Valeria Santini
Publikováno v:
Haematologica, Vol 104, Iss 1 (2019)
Externí odkaz:
https://doaj.org/article/49fd98bf53e04381b570812f4522d35e
Autor:
Michele Merli, Carlo Visco, Michele Spina, Stefano Luminari, Virginia Valeria Ferretti, Manuel Gotti, Sara Rattotti, Valeria Fiaccadori, Chiara Rusconi, Clara Targhetta, Caterina Stelitano, Alessandro Levis, Achille Ambrosetti, Davide Rossi, Luigi Rigacci, Alfonso Maria D’Arco, Pellegrino Musto, Annalisa Chiappella, Luca Baldini, Maurizio Bonfichi, Luca Arcaini
Publikováno v:
Haematologica, Vol 99, Iss 3 (2014)
A specific prognostication score for hepatitis C virus-positive diffuse large B-cell lymphomas is not available. For this purpose, the Fondazione Italiana Linfomi (FIL, Italian Lymphoma Foundation) carried out a multicenter retrospective study on a l
Externí odkaz:
https://doaj.org/article/746ab4dd878543b68f1cb782f55a170b
Autor:
Tamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, Federica Delaini, Claudio Romani, Enrico Maria Pogliani, Chiara Pagani, Emanuele Angelucci, Elisabetta Terruzzi, Alessandro Levis, Vincenzo Cassibba, Daniele Mattei, Giacomo Gianfaldoni, Anna Maria Scattolin, Eros Di Bona, Elena Oldani, Margherita Parolini, Nicola Gökbuget, Renato Bassan
Publikováno v:
Haematologica, Vol 98, Iss 11 (2013)
We evaluate the long-term results of a prospective clinical study enrolling more than 100 adult patients with Burkitt lymphoma/leukemia. Depending on extent of disease, treatment consisted of six to eight rituximab infusions and four to six courses o
Externí odkaz:
https://doaj.org/article/bf3bfa18f9264bb7b13fe32de4aaa3d1
Autor:
Francesco Zaja, Stefano De Luca, Umberto Vitolo, Lorella Orsucci, Alessandro Levis, Flavia Salvi, Chiara Rusconi, Erika Ravelli, Alessandra Tucci, Chiara Bottelli, Monica Balzarotti, Ercole Brusamolino, Maurizio Bonfichi, Stefano A. Pileri, Elena Sabattini, Stefano Volpetti, Chiara Monagheddu, Angelo Vacca, Roberto Ria, Renato Fanin
Publikováno v:
Haematologica, Vol 97, Iss 3 (2012)
Background Preclinical studies have highlighted the activity of lenalidomide in mantle cell lymphoma and its anti-proliferative synergy with dexamethasone.Design and Methods In this prospective, multicenter, phase II study, patients with relapsed/ref
Externí odkaz:
https://doaj.org/article/833ce7ee81f64cb5baddd32b512672e7
Autor:
Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, Giuseppe Rossi, Anna Marina Liberati, Maria Giuseppina Cabras, Barbara Botto, Giovannino Ciccone, Gianluca Gaidano, Lorenzo Falchi, Roberto Freilone, Domenico Novero, Lorella Orsucci, Vincenzo Pavone, Enrico Pogliani, Delia Rota-Scalabrini, Flavia Salvi, Anna Tonso, Alessandra Tucci, Alessandro Levis
Publikováno v:
Haematologica, Vol 94, Iss 9 (2009)
Background We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma.Design and Methods Ninety-four young patie
Externí odkaz:
https://doaj.org/article/e95f5885ff664ac9be3329bb97c79b2a
Autor:
Ercole Brusamolino, Andrea Bacigalupo, Giovanni Barosi, Giampaolo Biti, Paolo G. Gobbi, Alessandro Levis, Monia Marchetti, Armando Santoro, Pier Luigi Zinzani, Sante Tura
Publikováno v:
Haematologica, Vol 94, Iss 4 (2009)
The Italian Society of Hematology (SIE), the Italian Society of Experimental Haematology (SIES) and the Italian Group for Bone Marrow Transplantation (GITMO) commissioned a project to develop practice guidelines for the initial work-up, therapy and f
Externí odkaz:
https://doaj.org/article/f147ed51211a43e394712d53a6a19478
Autor:
Paola Tacchetti, Lucia Pantani, Francesca Patriarca, Maria Teresa Petrucci, Elena Zamagni, Luca Dozza, Monica Galli, Francesco Di Raimondo, Claudia Crippa, Mario Boccadoro, Simona Barbato, Patrizia Tosi, Franco Narni, Vittorio Montefusco, Nicoletta Testoni, Antonio Spadano, Carolina Terragna, Norbert Pescosta, Giulia Marzocchi, Claudia Cellini, Piero Galieni, Sonia Ronconi, Marco Gobbi, Lucio Catalano, Antonio Lazzaro, Giovanni De Sabbata, Clotilde Cangialosi, Fabrizio Ciambelli, Pellegrino Musto, Francesca Elice, Michele Cavo, Renato Fanin, Roberto Foa', Alessandro Rambaldi, Giuseppe Rossi, Pietro Leoni, Paolo Corradini, Giuseppe Torelli, Giuseppe Fioritoni, Sergio Cortelazzo, Giorgio Lambertenghi Deliliers, Giorgio La Nasa, Alfonso Zaccaria, Paolo De Fabritiis, Nicola Cascavilla, Alberto Bosi, Gianpietro Semenzato, Luigi Gugliotta, Filippo Gherlinzoni, Emanuele Angelucci, Massimo Fabrizio Martelli, Maria Concetta Petti, Giuseppe Leone, Angelo Michele Carella, Fabio Ciceri, Armando Santoro, Felicetto Ferrara, Francesco Nobile, Alfonso Maria D'Arco, Alessandro Levis, Luciano Guardigni, Andrea Gallamini, Pier Paolo Fattori, Sergio Morandi, Dino Amadori, Bruno Rotoli, Salvatore Mirto, Giorgio Paladini, Ruggero Mozzana, Graziella Pinotti, Francesco Rodeghiero, Nicola Cantore, Vincenzo Pavone, Enrico Maria Pogliani, Anna Marina Liberati, Ignazio Majolino, Sergio Amadori, Francesco Lauria, Massimo Aglietta, Giovanni Quarta, Sergio Storti, Fortunato Morabito, Silvana Franca Capalbo, Alessandro Massimo Gianni, Vincenzo Mettivier, Vittorio Rizzoli, Carlo Bernasconi, Giuseppe Visani, Michele Pizzuti, Giacinto La Verde, Giuseppe Avvisati, Maurizio Longinotti, Eugenio Gallo, Franco Dammacco, Domenico Russo, Andrea Bacigalupo, Caterina Musolino
Publikováno v:
The Lancet Haematology. 7:e861-e873
Background: The phase 3 GIMEMA-MMY-3006 trial, which compared bortezomib, thalidomide, and dexamethasone (VTD) combination therapy with thalidomide and dexamethasone (TD) as induction therapy before and consolidation therapy after double autologous h
Autor:
Luca Nassi, Anna Lia Molinari, Monica Tani, Pier Luigi Zinzani, Maurizio Bonfichi, Benedetta Puccini, Daniela Gioia, Alessandro Re, Alessandro Levis, Alessandro Pulsoni, Stefano Sacchi, Alessia Bari, Alessandra Tucci, Erika Meli, Chiara Pagani, Vincenzo Pavone, Raffaella Marcheselli, Umberto Vitolo, Andrea Evangelista, Barbara Botto, Armando Santoro
Publikováno v:
Ann Hematol
Annals of Hematology
Annals of Hematology
The International Prognostic Score (IPS) is the most commonly used risk stratification tool for patients with advanced Hodgkin lymphoma (HL). It incorporates seven clinical parameters independently associated with a poorer outcome: male sex, age, sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2fffad90d77afed15469bc6fb49f54d
https://hdl.handle.net/11380/1203344
https://hdl.handle.net/11380/1203344
Autor:
Elisa Masiera, Dario Ferrero, Antonella Poloni, Paolo Danise, Rodolfo Tassara, Pellegrino Musto, Carlo Finelli, Giovanni Cametti, Bernardino Allione, Emanuela Messa, Margherita Bonferroni, Valeria Santini, Alessandro Levis, Giuseppe Saglio, Alessandro Sanna, Enrico Balleari, Daniela Gioia, Flavia Salvi, Manuela Ceccarelli, Anna Castiglione
Publikováno v:
Haematologica. 104:e4-e8
Clinical guidelines recommend the use of erythropoietin-stimulating agents (ESA) in anemic patients with lower risk myelodysplastic syndrome (MDS)[1][1]–[4][2] and two registration trials for ESA have just been completed.[5][3],[6][4] We conducted
Autor:
Christa Fonatsch, Reinhard Stauder, Julie Schanz, Arjan A. van de Loosdrecht, Mario Cazzola, Yasushi Miyazaki, Francesc Solé, John M. Bennett, Wolfgang R. Sperr, David T. Bowen, Detlef Haase, Sigrid Machherndl-Spandl, Peter L. Greenberg, M. Slovak, Alessandro Levis, Luca Malcovati, Sudhir Tauro, Silvia Maria Meira Magalhães, Jaroslaw P. Maciejewski, Michael Pfeilstöcker, Heinz Tuechler, Peter Valent, Pierre Fenaux, Teresa Vallespi, Ulrich Germing, Guillermo Garcia-Manero, Mikkael A. Sekeres, Michael Luebbert, Andrea Kuendgen, Guillermo Sanz, François Dreyfus, Hagop M. Kantarjian, Michelle M. Le Beau, Jaroslav Cermak
Publikováno v:
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, 128(7), 902-910. American Society of Hematology
Pfeilstoecker, M, Tuechler, H, Sanz, G, Schanz, J, Garcia-Manero, G, Sole, F, Bennett, J M, Bowen, D, Fenaux, P, Dreyfus, F, Kantarjian, H, Kuendgen, A, Malcovati, L, Cazzola, M, Cermak, J, Fonatsch, C, Le Beau, M M, Slovak, M L, Levis, A, Luebbert, M, Maciejewski, J, Machherndl-Spandl, S, Magalhaes, S M M, Miyazaki, Y, Sekeres, M A, Sperr, W R, Stauder, R, Tauro, S, Valent, P, Vallespi, T, van de Loosdrecht, A A, Germing, U, Haase, D & Greenberg, P L 2016, ' Time-dependent changes in mortality and transformation risk in MDS ', Blood, vol. 128, no. 7, pp. 902-910 . https://doi.org/10.1182/blood-2016-02-700054
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, 128(7), 902-910. American Society of Hematology
Pfeilstoecker, M, Tuechler, H, Sanz, G, Schanz, J, Garcia-Manero, G, Sole, F, Bennett, J M, Bowen, D, Fenaux, P, Dreyfus, F, Kantarjian, H, Kuendgen, A, Malcovati, L, Cazzola, M, Cermak, J, Fonatsch, C, Le Beau, M M, Slovak, M L, Levis, A, Luebbert, M, Maciejewski, J, Machherndl-Spandl, S, Magalhaes, S M M, Miyazaki, Y, Sekeres, M A, Sperr, W R, Stauder, R, Tauro, S, Valent, P, Vallespi, T, van de Loosdrecht, A A, Germing, U, Haase, D & Greenberg, P L 2016, ' Time-dependent changes in mortality and transformation risk in MDS ', Blood, vol. 128, no. 7, pp. 902-910 . https://doi.org/10.1182/blood-2016-02-700054
In myelodysplastic syndromes (MDSs), the evolution of risk for disease progression or death has not been systematically investigated despite being crucial for correct interpretation of prognostic risk scores. In a multicenter retrospective study, we